Floatz logo

Fingolimod

Epilepsy in Pregnancy

Assistance Publique - Hôpitaux de ParisSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Epilepsy in Pregnancy cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Assistance Publique - Hôpitaux de Paris
N/AD
Natalizumab
Assistance Publique - Hôpitaux de Paris
N/AD
Glatiramer
Assistance Publique - Hôpitaux de Paris
N/AD
2-BUTENEDIOIC ACID, (2E)-, DIMETHYL ESTER
Assistance Publique - Hôpitaux de Paris
N/AD
Teriflunomide
Assistance Publique - Hôpitaux de Paris
N/AD

Same molecule, other indications

Fingolimod is also rated in:

relapsing-remitting multiple sclerosisDormant
A
Indicative ·
82 / 100
View asset →
multiple sclerosisDormant
BB
Indicative ·
70 / 100
View asset →
cerebral degenerationDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →